Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up R&B singer John Legend is about to jump into the business side of ...
The Roc-A-Fella Records cofounder is still salty that Legend never signed to his label in the early 2000s. During a recent interview with “The Art of Dialogue,” Dash opened up about the artists who ...
The U.S. Food and Drug Administration (FDA) has approved a label update for Legend Biotech (NASDAQ:LEGN) and Johnson & Johnson (NYSE:JNJ) unit Janssen's multiple myeloma treatment Carvykti to include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback